Search

everythinglearnresearchcommunity

for

Search:↓

Injecting specific cells into the skin can help improve skin structure and reduce blisters in a genetic skin disorder.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.

rRSPO1 protein boosts hair growth by activating a key signaling pathway.

Upadacitinib may cause hair loss.

5ARI treatment improves hair growth in older men with minimal side effects.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Finasteride reduces movement issues in Parkinson's disease rats.

Advanced hydrogels can autonomously deliver drugs to treat radiation skin injuries, but challenges remain for clinical use.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Aged Julia Creek dunnarts suffer from reproductive and hormonal issues, aiding conservation efforts.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Two red-haired men with alopecia areata regrew black hair instead of red.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

People with autism are more likely to develop alopecia areata than those without autism.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.